In a 1st, scientists use designer immune cells to send an autoimmune disease into remission

Österreich Nachrichten Nachrichten

In a 1st, scientists use designer immune cells to send an autoimmune disease into remission
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 LiveScience
  • ⏱ Reading Time:
  • 66 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 51%

The therapy will now be tested in larger trials.

Five patients with hard-to-treat lupus entered remission after scientists tweaked their immune cells using a technique normally used to treat cancer. After the one-time therapy, all five patients with the autoimmune disease stopped their standard treatments and haven't had a relapse.

"It's a single shot of CAR T cells and patients stop all treatments," Schett told Live Science."We were really surprised [at] how good this effect is." Rebooting the immune system Lupus is a chronic disease in which the immune system inadvertently attacks the body's own cells, resulting in inflammation, tissue damage, pain and fatigue.

Schett's group theorized that such treatment-resistant lupus patients could potentially benefit from CAR T-cell therapy, which has previously been used to treat cancer patients. During CAR T-cell therapy, doctors extract immune cells, called T cells, from a patient's blood, genetically tweak those T cells in the lab and then inject them back into the patient's body, according to the NIH's National Cancer Institute .

The other four patients' also started making new B cells within months of treatment, without relapsing. It seems as though rebooting the B cell system in this way may prevent the disease from coming back — but they'll need to keep monitoring the patients to be sure, Schett said.—A cancer 'vaccine' cured 97% of tumors in mice. What's that mean for people?"The mean follow up of 8 months is too early to determine whether this is complete remission," said Dr.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

LiveScience /  🏆 538. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Genetically modified immune cells put 5 people's lupus in remissionGenetically modified immune cells put 5 people's lupus in remissionMore than six months after CAR-T cell treatment, five patients are in remission and have functional immune systems.
Weiterlesen »

New Treatment Turns Cancer Genes Into 'Eat Me' Signs For Immune SystemNew Treatment Turns Cancer Genes Into 'Eat Me' Signs For Immune SystemScientists at UCSF say they've developed a new treatment that causes cancer cells to rat on themselves, allowing the immune system to easily kill them.
Weiterlesen »

Cell-killing cancer therapy shows promise for a devastating autoimmune disorderOpening a new frontier in fighting autoimmune disease, researchers have successfully treated five lupus patients with a novel cell therapy that turns run-of-the-mill immune cells into specialized hunters of rogue cells helping fuel illness.
Weiterlesen »

How a ‘Living Drug’ Could Treat Autoimmune DiseaseHow a ‘Living Drug’ Could Treat Autoimmune DiseaseCAR-T therapy has been successful at treating cancer. Now, it’s driven lupus into remission in a handful of patients.
Weiterlesen »

Worries over stigma are driving a push to rename monkeypox, but the process is slow | CNNWorries over stigma are driving a push to rename monkeypox, but the process is slow | CNNSince the beginning of the monkeypox outbreak, scientists and activists have pushed for the name of the virus and the disease to be changed to something 'non-discriminatory' and 'non-stigmatizing.'
Weiterlesen »



Render Time: 2025-04-02 04:28:18